Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
artificial blood substitute
|
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:alternativeTo |
human blood transfusion
|
| gptkbp:approvalYear |
1989
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:category |
perfluorocarbon-based oxygen carrier
|
| gptkbp:component |
perfluorodecalin
perfluorotripropylamine |
| gptkbp:developedBy |
gptkb:Green_Cross_Corporation
|
| gptkbp:discontinued |
1994
adverse reactions complex administration limited efficacy |
| gptkbp:form |
emulsifier
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fluosol-DA
|
| gptkbp:marketedIn |
gptkb:Japan
gptkb:United_States |
| gptkbp:notDerivedFrom |
human blood
animal blood |
| gptkbp:storage |
refrigerated
|
| gptkbp:usedFor |
oxygen transport
patients unable to receive blood transfusions patients with severe anemia |
| gptkbp:bfsParent |
gptkb:Blood_Substitute
|
| gptkbp:bfsLayer |
7
|